Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
LetterCovid Commentaries
Open Access

Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic: Are There Any Concerns?

Lisa Bodei, Emily Bergsland, Wouter W. de Herder, Diego Ferone, Rodney J. Hicks, Thomas A. Hope, Jolanta Kunikowska, Marianne Pavel, Diane Reidy-Lagunes, Jens Siveke, Jonathan Strosberg, Ulf Dittmer and Ken Herrmann
Journal of Nuclear Medicine August 2020, 61 (8) 1094-1095; DOI: https://doi.org/10.2967/jnumed.120.249136
Lisa Bodei
1Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emily Bergsland
2Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wouter W. de Herder
3Erasmus MC and Erasmus MC Cancer Center, ENETS Center of Excellence Rotterdam, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diego Ferone
4Endocrinology Unit, IRCCS Ospedale Policlinico San Martino, and Department of Internal Medicine and Medical Specialties, University of Genova, Genova, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rodney J. Hicks
5Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas A. Hope
6Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jolanta Kunikowska
7Nuclear Medicine Department, Medical University of Warsaw, Warsaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marianne Pavel
8Department of Medicine 1, Endocrinology, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen and Nürnberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diane Reidy-Lagunes
9Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jens Siveke
10Institute for Developmental Cancer Therapeutics, West German Cancer Center, University Hospital Essen, Essen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan Strosberg
11Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, Florida
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ulf Dittmer
12Institute for Virology, University Hospital Essen, Essen, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken Herrmann
13Department of Nuclear Medicine, University Hospital Essen, Essen, Germany, and Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 61 no. 8 1094-1095
DOI 
https://doi.org/10.2967/jnumed.120.249136
PubMed 
32576637

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication May 6, 2020
  • Accepted for publication June 6, 2020
  • Published online August 3, 2020.

Article Versions

  • previous version (June 23, 2020 - 09:19).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2020 by the Society of Nuclear Medicine and Molecular Imaging. Immediate Open Access: Creative Commons Attribution 4.0 International License (CC BY) allows users to share and adapt with attribution, excluding materials credited to previous publications. License: https://creativecommons.org/licenses/by/4.0/. Details: http://jnm.snmjournals.org/site/misc/permission.xhtml.

Author Information

Statistics from Altmetric.com

Cited By...

  • 7 Citations
  • 6 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Targeted radionuclide therapy: an emerging field in solid tumours
    Carlos Artigas, Magdalena Mileva, Patrick Flamen, Ioannis Karfis
    Current Opinion in Oncology 2021 33 5
  • Professional Assessment of the Impact of COVID-19 on Handling NET Patients
    Sebastian Krug, Jakob Garbe, Senta König, Hanna Ungewiss, Patrick Michl, Anja Rinke, Jörg Schrader
    Journal of Clinical Medicine 2020 9 11
  • Impact of the COVID-19 pandemic on neuroendocrine tumour services in England
    Martin O. Weickert, Tim Robbins, Ioannis Kyrou, Adam Hopper, Eilish Pearson, Thomas M. Barber, Gregory Kaltsas, Harpal S. Randeva
    Endocrine 2021 71 1
  • The Impact of COVID-19 on Nuclear Medicine in Europe
    Margarita Kirienko, Silvi Telo, Roland Hustinx, Jamshed B. Bomanji, Arturo Chiti, Stefano Fanti
    Seminars in Nuclear Medicine 2022 52 1
  • Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study
    Nicola Fazio, Lorenzo Gervaso, Thorvardur R. Halfdanarson, Anna La Salvia, Johannes Hofland, Jorge Hernando, Mohamad B. Sonbol, Rocio Garcia-Carbonero, Jaume Capdevila, Wouter W. de Herder, Anna Koumarianou, Gregory Kaltsas, Maura Rossi, Simona Grozinsky-Glasberg, Kira Oleinikov, Sabrina Boselli, Darina Tamayo, Vincenzo Bagnardi, Alice Laffi, Manila Rubino, Francesca Spada
    European Journal of Cancer 2021 154
  • Dosimetry of [177Lu]Lu-DOTATATE in Patients with Advanced Midgut Neuroendocrine Tumors: Results from a Substudy of the Phase III NETTER-1 Trial
    Lisa Bodei, Marta Cremonesi, Mahila Ferrari, Erik S. Mittra, Harshad R. Kulkarni, Christophe M. Deroose, Rajaventhan Srirajaskanthan, John Ramage, Chiara Maria Grana, Francesca Botta, Matthias M. Weber, Matthias Miederer, Ryan Reddy, Daniela Chicco, Maurizio F. Mariani, Arnaud Demange, Jack L. Erion, Germo Gericke, Eric Krenning
    Journal of Nuclear Medicine 2025 66 3

Article usage

Article usage: June 2020 to April 2025

AbstractFullPdf
Jun 202000943
Jul 2020002095
Aug 20200393406
Sep 202008064
Oct 202005338
Nov 202004338
Dec 202007143
Jan 2021011236
Feb 202105522
Mar 2021010431
Apr 202106727
May 202109628
Jun 202105512
Jul 202103841
Aug 202103723
Sep 202101814
Oct 202107938
Nov 202101421
Dec 202102722
Jan 202201216
Feb 202201912
Mar 202202315
Apr 202202011
May 202201818
Jun 202202212
Jul 20220193
Aug 20220165
Sep 202202313
Oct 202202213
Nov 20220107
Dec 20220168
Jan 202301513
Feb 202302316
Mar 20230117
Apr 202302912
May 20230163
Jun 20230169
Jul 20230107
Aug 2023089
Sep 20230106
Oct 20230813
Nov 20230187
Dec 202302210
Jan 20240235
Feb 20240516
Mar 202401079
Apr 202405124
May 202404018
Jun 202402810
Jul 202402410
Aug 202402911
Sep 20240259
Oct 20240216
Nov 20240235
Dec 20240106
Jan 20250106
Feb 202506445
Mar 202504624
Apr 202502218
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 61 (8)
Journal of Nuclear Medicine
Vol. 61, Issue 8
August 1, 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic: Are There Any Concerns?
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic: Are There Any Concerns?
Lisa Bodei, Emily Bergsland, Wouter W. de Herder, Diego Ferone, Rodney J. Hicks, Thomas A. Hope, Jolanta Kunikowska, Marianne Pavel, Diane Reidy-Lagunes, Jens Siveke, Jonathan Strosberg, Ulf Dittmer, Ken Herrmann
Journal of Nuclear Medicine Aug 2020, 61 (8) 1094-1095; DOI: 10.2967/jnumed.120.249136

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic: Are There Any Concerns?
Lisa Bodei, Emily Bergsland, Wouter W. de Herder, Diego Ferone, Rodney J. Hicks, Thomas A. Hope, Jolanta Kunikowska, Marianne Pavel, Diane Reidy-Lagunes, Jens Siveke, Jonathan Strosberg, Ulf Dittmer, Ken Herrmann
Journal of Nuclear Medicine Aug 2020, 61 (8) 1094-1095; DOI: 10.2967/jnumed.120.249136
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Dosimetry of [177Lu]Lu-DOTATATE in Patients with Advanced Midgut Neuroendocrine Tumors: Results from a Substudy of the Phase III NETTER-1 Trial
  • Google Scholar

More in this TOC Section

  • Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 Patients
  • Low-Dose Radiation to COVID-19 Patients to Ease the Disease Course and Reduce the Need of Intensive Care
  • Oncology-Inspired Treatment Options for COVID-19
Show more Covid Commentaries

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire